Boston, MAPhone: 617-523-7900
About Thomas Dohlman, MD
Dr. Dohlman is a full-time member of the Cornea and Refractive Surgery Service at Mass. Eye and Ear who specializes in the medical and surgical management of corneal and external diseases.
Dr. Dohlman earned his Bachelor of Science degree from MIT and MD from the University of Massachusetts Medical School. He then completed a Postdoctoral Research Fellowship in Transplantation and Ocular Immunology at the Schepens Eye Research Institute of Mass. Eye and Ear. He went on to complete his residency training in ophthalmology at New York Presbyterian/Weill Cornell Medical College, after which he returned to Mass. Eye and Ear for further subspecialty training as an Advanced Two-Year Combined Clinical and Research Fellow in Cornea, Refractive Surgery, and External Disease.
Following fellowship, Dr. Dohlman joined the faculty at Harvard Medical School and Mass. Eye and Ear as an NIH-funded clinician scientist, caring for patients and conducting basic science and clinical research in the areas of corneal immunology and inflammation, corneal fibrosis/scarring and ocular surface disease.
- Cornea and external diseases
Mass. Eye and Ear
243 Charles St.
Boston, MA 02114
- MD, UMass Memorial Medical School
- Residency, New York Presbyterian Hospital
- Fellowship, Massachusetts Eye and Ear***
- Fellowship, Schepens Eye Research Institute
American Board Certifications
- Ophthalmology, American Board of Ophthalmology
Accepted Insurance Plans
- Medicare ACO - ACD
- Medicare ACO - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Dohlman is a clinician scientist who specializes in the diagnosis and management of corneal disease. He conducts basic science research investigating the immunoinflammatory mechanisms underlying corneal transplantation rejection and corneal fibrosis/scarring, with an over-arching goal of bringing insights from this work to clinical practice. Dr. Dohlman's clinical research focuses on advancing our understanding of corneal transplantation rejection, ocular surface disease, and corneal opacity in order to identify and develop novel therapeutic strategies for these conditions.
1. Singh RB, Zhu S, Yung A, Dohlman TH, Dana R, Yin J. Efficacy of cyanoacrylate tissue adhesive in the management of corneal thinning and perforation due to microbial keratitis. Ocul Surf. 2020 Aug 19.
2. Singh RB, Yung A, Coco G, Sinha S, Dohlman TH, Yin J, Dana R. Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease. Ocul Surf. 2020 Jul 29.
3. Sinha S, Singh RB, Dohlman TH, Wang M, Taketani Y, Yin J, Dana R. Prevalence of Persistent Corneal Epithelial Defects in Chronic Ocular Graft-Versus-Host Disease. Am J Ophthalmol. 2020 Jul 25; 218:296-303
4. Taketani Y, Marmalidou A, Dohlman TH, Singh RB, Amouzegar A, Chauhan SK, Chen Y, Dana R. Restoration of Regulatory T-Cell Function in Dry Eye Disease by Antagonizing Substance P/Neurokinin-1 Receptor. Am J Pathol. 2020 Sep; 190(9):1859-1866.
5. Fan NW, Dohlman TH, Foulsham W, McSoley M, Singh RB, Chen Y, Dana R. The role of Th17 immunity in chronic ocular surface disorders. Ocul Surf. 2020 May 26.
#1 Research Hospital in America
Mass General is the #1 hospital in New England based on U.S. News & World Report Best Hospitals for 2022-2023.
Reviews: Comments and Ratings